Related Experiment Videos
Immunoassay for single-stranded DNA in apoptotic cells.
1University of Miami Medical School, FL, USA.
Methods in Molecular Biology (Clifton, N.J.)
|April 24, 2004
Summary
This study introduces a novel apoptosis assay detecting early and late apoptotic cells via DNA denaturation and specific antibody detection. This method accurately identifies apoptosis in tissues and cell suspensions, aiding drug screening.
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- Apoptosis, or programmed cell death, is crucial for development and disease.
- Accurate detection of apoptosis is vital for understanding cellular processes and drug efficacy.
- Existing methods may lack specificity or sensitivity for early/late apoptotic stages.
Purpose of the Study:
- To present a sensitive and specific assay for detecting apoptotic cells.
- To validate the assay's performance in various biological samples.
- To explore its application in high-throughput drug screening.
Main Methods:
- Selective denaturation of DNA in condensed chromatin of apoptotic cells.
- Detection using a monoclonal antibody specific to single-stranded DNA.
- Application in immunohistochemistry, flow cytometry, fluorescence microscopy, and enzyme-linked immunoassay.
Main Results:
- The assay specifically detects apoptotic cells, distinguishing them from necrotic cells or those with non-apoptotic DNA breaks.
- It demonstrates sensitivity to both early and late stages of apoptosis.
- The enzyme-linked immunoassay effectively screens drugs, predicting toxicity and synergism.
Conclusions:
- The described apoptosis assay offers a sensitive and specific method for identifying apoptotic cells.
- It is adaptable for diverse detection platforms, including tissue sections and cell suspensions.
- The enzyme-linked immunoassay provides a valuable tool for high-throughput drug discovery and evaluation.